Mark Sanner
14Patents
6h-index
19Co-inventors
55Inventor score
Filing activity: Dec 23, 1996 → Jun 15, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6720427B2 | Thiazole derivatives | Chemistry; Metallurgy | 110 | Expired |
| US6284757A | Pyrrolo[1,2-a]pyrazine derivatives as 5HT1A ligands | Human Necessities | 27 | Expired |
| US5883094A | Benzimidazolone derivatives with central dopaminergic activity | Chemistry; Metallurgy | 25 | Expired |
| US6372736B1 | Heterocyclic compounds as inhibitors of rotamase enzymes | Chemistry; Metallurgy | 21 | Expired |
| US6548502B2 | Dopamine D4 ligands for the treatment of novelty-seeking disorders | Human Necessities | 7 | Expired |
| US5852031A | 2,7-substituted octahydro-1H-pyrido1,2-a!pyrazine derivatives | Human Necessities | 6 | Expired |
| US5889010A | Benzimidazole derivatives having dopaminergic activity | Chemistry; Metallurgy | 6 | Expired |
| US6756385B2 | Imidazole derivatives | Chemistry; Metallurgy | 5 | Expired |
| US7101885B2 | Piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams | Chemistry; Metallurgy | 3 | Expired |
| US7078529B2 | Imidazole derivatives | Chemistry; Metallurgy | 3 | Expired |
| US6231833A | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors | Human Necessities | 2 | Expired |
| US5714487A | 2,7-substituted octahydro-pyrrolo1,2-a!pyrazine derivatives | Human Necessities | 2 | Expired |
| US6562964B1 | Heterocyclic compounds as inhibitors of rotamase enzymes | Chemistry; Metallurgy | 0 | Expired |
| US7220753B2 | 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.